Navigation Links
Encorium Reports Second Quarter 2010 Financial Results
Date:8/17/2010

WAYNE, Pa., Aug. 17 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced its financial results for the second quarter and six months ended June 30, 2010.

As previously announced, on July 16, 2009 the Company sold substantially all of the assets relating to its U.S. line of business to Pierrel Research USA, Inc., the result of which the Company no longer has any employees or significant operations in the United States.  Due to this sale, for the three months ended June 30, 2010, the results of the U.S. business have been presented as discontinued operations in the Company's consolidated financial statements.

2010 Second Quarter Financial ResultsNet revenue for the second quarter of 2010 was 3.8 million, a $700 thousand decrease from $4.5 million for the second quarter of 2009.  The decrease in net revenues was primarily attributable to reduced new business awards, contract cancellations as well as performance of unexpected out of scope work for which revenue can not be recognized until corresponding change orders are executed with the clients.  Of the $700 thousand decrease, approximately $325 thousand was due to unfavorable foreign currency fluctuations for the three months ended June 30, 2010.  

The Company had a consolidated backlog at June 30, 2010 of $16.6 million compared to backlog at March 31, 2010 of $14.7 million and backlog of $19.6 million at June 30, 2009.  For the six months ended June 30, 2010 we obtained approximately $9.1 million of new business awards as compared to approximately $4.8 million for the six months ended June 30, 2009.

Direct expenses for the second quarter of 2010 declined to $2.6 million, or
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
3. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
4. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
5. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
6. Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... -- Pharmatech initiated enrollment for its AccessPPM program ... for matching cancer patients to cancer clinical trials. ... cancers, disease staging, and genetic mutations - which ... the first place. The challenge that the industry ... well known to the patient or even their ...
(Date:8/28/2014)... , Aug. 28, 2014 Tianyin Pharmaceutical ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today updates the timeline ... Facility (QLF). The Company is ... dataset for China Food & Drug Administration,s (CFDA) ...
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2
... May 30, 2012   AssureRx Health, Inc. ... Series C financing. The personalized medicine company, which ... right drug for individual neuropsychiatric patients, will use ... two flagship pharmacogenomic products, GeneSightRx® Psychotropic and GeneSightRx® ...
... 2012 The use of an armband-based body monitoring ... approaches to weight loss examined by researchers in an ... of Sports Medicine,s 59th Annual Meeting and 3rd ... in San Francisco. The study, "An Economic Analysis of ...
Cached Medicine Technology:AssureRx Health Raises $12.5 Million Series C Financing 2AssureRx Health Raises $12.5 Million Series C Financing 3AssureRx Health Raises $12.5 Million Series C Financing 4Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 2Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 3
(Date:8/28/2014)... 2014 UWDress.com, an internationally famous designer ... unveiled its fashionable assortment of fall bridesmaid dresses ... and old customers, the company is now providing big ... company’s discounted fall bridesmaid outfits are offered in many ... collection are priced less than $190. UWDress.com’s kind officials ...
(Date:8/28/2014)... these particular arguments against the policy, put forward by ... the first country in the world to introduce standardised ... Ireland, and the UK are currently considering similar legislation. ... policy would deter people from buying their tobacco from ... of cheap products sourced from Asia, and increase the ...
(Date:8/28/2014)... Recently, iFitDress.com, the distinguished wedding dress manufacturer and retailer, ... dresses . Included in the new range are hundreds ... are provided at deeply discounted prices, from 22 to ... and reliable delivery service. All clients from around the ... time. As is commonly noted, international customers have different ...
(Date:8/28/2014)... of women who are given information about the chance ... not fully understand the risks involved, according to research ... , today (Friday). , In a survey of around ... London (UCL) found that 64 per cent felt they ... chance that screening will pick up cancers that would ...
(Date:8/28/2014)... 2014 Blood's Thicker Than Water is based ... family ties in the heart of the city. Raymond E. ... story about how disrespect caused two families to collide with ... , The Yayo Boyz and the M.O.B. Boyz clash in ... local onlookers in a silent terror. "Guerrilla," AKA "Real," runs ...
Breaking Medicine News(10 mins):Health News:Fashionable Fall Bridesmaid Dresses From UWDress.com 2Health News:Plain cigarette packs don't hurt small retailers or boost trade in illicit tobacco 2Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2
... (June 24, 2010) The nerve cell-damaging plaque that ... builds up in the retinas of the eyes ... prospect that noninvasive optical imaging of the eyes could ... disease, according to new research. Scientists discovered characteristic ...
... of large sessile colorectal polyps is increasingly used as ... its technical difficulty, the high risk of complications such ... malignancy. This research, lead by Dr. Sohn DK ... demonstrated the safety of endoscopic piecemeal resection (EPMR) for ...
... may increase the risk of severe asthma attacks among people ... Harvard Medical School, Harvard Pilgrim Health Care Institute and Brigham ... on the American Thoracic Society,s journal Web site ahead of ... and Critical Care Medicine . "We found that the ...
... School of Medicine has received a $5.3 million grant from ... four-year clinical trial to show the effects of weight loss ... co-existing medical conditions in overweight breast cancer survivors. ,This ... study that will examine the effect of weight loss on ...
... coping with stress succumb easily to substance use cravings, ... to behavioral researchers. "Cravings are a strong predictor of ... development, Penn State. "The goal of this study is ... person on a within-day basis. Because recovery must be ...
... A pair of University of California San Diego researchers ... and disorders, and Yang Xu, an immunologist have ... from the California Institute for Regenerative Medicine (CIRM). ... Immunology awards totaling $25 million that were approved at ...
Cached Medicine News:Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 2Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 3Health News:Moldy homes a serious risk for severe asthma attacks in some 2Health News:UC San Diego researcher awarded $5.3 million for breast cancer survivorship study 2Health News:Ignoring stress leads recovering addicts to more cravings 2Health News:UCSD researchers receive $2.5 million in new stem cell grants 2
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
... Control is designed to ... significant range of those ... during fertility or pregnancy ... hCG-Beta Subunit levels allow ...
... provides the clinical laboratory with the ... for monitoring immunoassay and therapeutic drug ... separate controls. Made from human serum ... suitable for most methods and is ...
Lyphochek Immunology Plus Control is an assayed control for monitoring chemistry procedures that test for autoimmune, anemic, malignant, hepatic and nephrotic-disease states. Available in two levels....
Medicine Products: